Share this link via:
The Point of Care Testing Market size was valued at around 49.7 Billion in 2023 and is expected to reach a value of USD 111.56 Billion by 2032, at a CAGR of 9% over the forecast period (2024–2032).
The Global Point of Care Testing (POCT) Market is determined by the necessity of near-patient accurate and rapid diagnostic solutions. POCT allows health care professionals to make immediate clinical decisions by delivering timely results-not only in emergency and critical care situations but also while managing patients with chronic disease. The widespread adoption of point-of-care testing across health care systems-from hospitals and clinics to home care environments-is driven by the need for speedier diagnosis to improve patient outcomes, shorten hospital stays, and cap overall health care costs.
The main technologies that have resulted in the growth of the POCT Market include innovations in miniaturization, integration into digital health tools, improvements in biosensors, microfluidics, and molecular diagnostics. These innovations have improved accuracy, reliability, and ease of use in POCT devices. Growth in the serious incidence of chronic diseases like diabetes, cardiovascular diseases and infectious diseases is expected to further create a demand for regular testing and monitoring.
The change from centralized systems to decentralized health care along with the growing importance of preventive care has also energized interest in POCT. In their global quest toward patient-centric healthcare, point of care testing would certainly supply all the flexibility and convenience required by the evolving healthcare environment. Hence the point of care testing market is expected to continue expanding vigorously in the years to come, facilitated further by coming up with innovations in technology and increasing levels of patient awareness.
Key Findings:
The market scope is segmented because of by Product Type, by Platform, by Mode of Purchase, by Application, by End User.
Based on the Product Type of the market is segmented into Glucose Monitoring Kits, Infectious Disease Testing Kits, Cardiometabolic Monitoring Kits, Coagulation Testing Kits, Hematology Testing Kits, Pregnancy and Fertility Testing Kits, Tumor/Cancer Marker Testing Kits, Urinalysis Testing Kits, Cholesterol Testing Kits, Drugs of Abuse Testing Kits.
Among the diverse range of product types in the Point of Care Testing (POCT) Market, Glucose Monitoring Kits have perennially captured the maximum market share. The ever-increasing prevalence of diabetes worldwide has ushered in phenomenal demand for continuous glucose monitoring for management, making this segment the largest of all. As most countries in the world contain millions of new diabetes cases every year, according to the International Diabetes Federation (IDF), a huge population percentage is estimated to have diabetes. This condition continually requires blood glucose monitoring to avert any complications such as hyperglycemia or hypoglycemia. The glucose monitoring kits have therefore become very valuable to patients and their health care providers.
They are also easy to use, helping to ensure the widespread use of glucose monitoring kits. These kits allow diabetic patients to monitor their blood sugar levels at home or on the go, reducing the need for frequent visits to healthcare facilities. This segment is experiencing growth as patient self-care becomes more common, coupled with modern portable devices capable of accurate readings in seconds. At the same time, advancements like continuous glucose monitoring systems also contribute to the growth of the market. These innovations offer real-time data through wearable devices.
Based on the Platform of the market is segmented into Lateral Flow Assays, Immunoassays, Molecular Diagnostics, Dipsticks, Microfluidics.
The several platform segments in the Point of Care Testing (POCT) Market, the Lateral Flow Assays (LFAs) have led it. They are extremely user-friendly, inexpensive and highly efficient diagnostic tools that have found immense popularity because of their usefulness in a variety of one-step sample test formats. These include applications for infectious disease detection, pregnancy testing, or drugs of abuse testing, because they detect specific antigens or antibodies in any of several bodily samples, including blood, urine, or saliva.
Perhaps one of the many things that make LFAs the leading test in this segment is the turnaround time. Lateral flow assays give nearly instant results. It is only beneficial in settings where fast decision-making is imperative. For their portability and lack of dependence on complex laboratory equipment for functioning, these tests can be highly effective in various settings, including home care, remote, or resource-limited settings. Besides, the COVID-19 pandemic has further propelled the requirement for lateral flow assays. They have served as the basic pillar of rapid testing strategies around the world and enabled mass testing and screening with a very efficient methodology.
By region, Insights into the markets in North America, Europe, Asia-Pacific, Latin America and MEA. Historically, North America has always been the leader in POCT. This is primarily a result of the chronic disease conditions, such as diabetes, cardiovascular disorders, and cancers that need to be tested more frequently and easily. The region has well-built infrastructures of health care along with several major players like Abbott Laboratories, Danaher Corporation, Becton Dickinson, which also have been contributing to the high uptake of POCT in the region. Moreover, the strong emphasis on innovation and an early adoption of advanced diagnostics, such as molecular diagnostics and wearable monitoring devices, have been facilitating the advancement of POCT in North America. Government initiatives aimed at better access to healthcare and supporting reimbursement have also been instrumental in developing the POCT Market in this part of the region.
In the forecast period, Asia-Pacific is expected to remain the fastest-growing region in the world POCT Market, as the rise in population, the increase in chronic diseases, and the improvement in healthcare infrastructure are most robustly needed in this region, particularly in countries like China, India, and Japan. Meanwhile, growing awareness of early diagnosis and preventive healthcare coupled with increased health care expenditure are driving the demand for POCT devices in this region. Important factors include a middle-class growing population and decentralized healthcare, which will also contribute to the region's overall strong growth, positioning Asia-Pacific as a high-potential area for POCT Market development.
The report will cover the qualitative and quantitative data on the Global Point of Care Testing Market. The qualitative data includes latest trends, market players analysis, market drivers, market opportunity, and many others. Also, the report quantitative data includes market size for every region, country, and segments according to your requirements. We can also provide customize report in every industry vertical.
Study Period | 2024-32 |
Base Year | 2023 |
Estimated Forecast Year | 2024-32 |
Growth Rate | CAGR of 9% from 2024 to 2032 |
Segmentation | By Product Type, By Platform, By Mode of Purchase, By Application, By End User, By Region |
Unit | USD Billion |
By Product Type |
|
By Platform |
|
By Mode of Purchase |
|
By Application |
|
By End User |
|
By Region |
|
North America accounted for the highest xx% market share in terms of revenue in the Point of Care Testing market and is expected to expand at a CAGR of xx% during the forecast period. This growth can be attributed to the growing adoption of Point of Care Testing. The market in APAC is expected to witness significant growth and is expected to register a CAGR of xx% over upcoming years, because of the presence of key Point of Care Testing companies in economies such as Japan and China.
The objective of the report is to present comprehensive analysis of Global Point of Care Testing Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language.
Point of Care Testing Market Report is also available for below Regions and Country Please Ask for that
Point of Care Testing Market Trends: Market key trends which include Increased Competition and Continuous Innovations Trends:
You'll get the sample you asked for by email. Remember to check your spam folder as well. If you have any further questions or require additional assistance, feel free to let us know via-
+1 724 648 0810 +91 976 407 9503 sales@intellectualmarketinsights.com
20 Jun 2022
Intellectual Market Insights Research © 2026. All rights reserved.
